ADMA — ADMA BIOLOGICS INC

Ownership history in Caption Management, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q2)
Avg. % of fund
0.04%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 312,500 +262,500 +525.0% 0.04% $5.7M $18.24
2025 Q4 REDUCED 50,000 -145,000 -74.4% 0.01% $912K $18.24
2025 Q3 REDUCED 195,000 -102,500 -34.5% 0.02% $2.9M $14.66
2025 Q3 REDUCED 297,500 -35,000 -10.5% 0.03% $4.4M $14.66
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%
← Back to Caption Management, LLC Holdings